Characterization of recombinant human apoB-48-containing lipoproteins in rat hepatoma McA-RH7777 cells transfected with apoB-48 cDNA. Overexpression of apoB-48 decreases synthesis of endogenous apoB-100.

We studied the effect of overexpression of apolipoprotein (apo) B-48 on the synthesis and secretion of endogenous apoB-100 in rat hepatoma McA-RH7777 cell lines stably transfected with human apoB-48 cDNA under the control of the cytomegalovirus promoter. Three cell lines that secrete 40 to 60 ng human apoB.mg cell protein-1.h-1 were used. The recombinant human apoB-48 exhibited physicochemical characteristics (buoyant density, 1.06 to 1.21 g/mL; beta-electrophoretic mobility and diameters, 16 to 20 nm) indistinguishable from those of endogenous rat apoB-48. Overexpression of the recombinant human apoB-48 resulted in a 50% decrease in the secretion of endogenous apoB-100 but did not affect the secretion of apoE or apoA-I. Several possible mechanisms for the decreased secretion of apoB-100 were evaluated. First, recruitment of lipids into lipoproteins was shown to be unaffected since no major changes in the physicochemical properties of apoB-100-containing lipoproteins were observed. Second, the intracellular degradation of apoB-100 was not altered as the intracellular retention half-time and secretion efficiency remained unaffected by apoB-48 overexpression. Third, the posttranslational regulatory mechanisms for apoB-100 remained normal, as demonstrated by a twofold increase in apoB-100 secretion after supplementation with oleic acid. Unexpectedly, a 35% to 50% decrease in the steady-state synthesis of endogenous apoB-100 was observed in apoB-48-transfected cells compared with control cells. These data suggested that decreased secretion of apoB-100 was secondary to decreased synthesis. The decreased apoB-100 synthesis was not due to decreased steady-state levels of rat apoB-100 mRNA. These results suggest that overexpression of recombinant human apoB-48 may interfere with posttranscriptional events, possibly at the translation-translocation level, and decrease translational yield of apoB-100. These posttranscriptional events prior to the complete synthesis of the apoB-100 polypeptide can be important in the control of apoB-100 secretion.

[1]  E. Fisher,et al.  The effects of n-3 fatty acids on the secretion of carboxyl-terminally truncated forms of human apoprotein B. , 1994, The Journal of biological chemistry.

[2]  R. Raghow,et al.  Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. McLeod,et al.  Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. , 1994, Biochimica et biophysica acta.

[4]  T. Okita,et al.  Targeting of mRNAs to domains of the endoplasmic reticulum. , 1994, Trends in cell biology.

[5]  R. McLeod,et al.  Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins. , 1994, The Journal of biological chemistry.

[6]  L. Chan,et al.  Apolipoprotein B synthesis: a square lattice model. , 1994, Journal of lipid research.

[7]  J. Borén,et al.  Influence of triacylglycerol biosynthesis rate on the assembly of apoB-100-containing lipoproteins in Hep G2 cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  H. Greten,et al.  Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. , 1993, Journal of lipid research.

[9]  X. Chen,et al.  N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. , 1993, The Journal of clinical investigation.

[10]  H. Ginsberg,et al.  Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. , 1993, Journal of lipid research.

[11]  K. Adeli,et al.  Insulin modulation of human apolipoprotein B mRNA translation: studies in an in vitro cell-free system from HepG2 cells. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[12]  D. Rader,et al.  Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. , 1992, Science.

[13]  J. Scott,et al.  Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. , 1992, The Journal of biological chemistry.

[14]  Robert V Farese,et al.  Modification of the apolipoprotein B gene in HepG2 cells by gene targeting. , 1992, The Journal of clinical investigation.

[15]  J. Borén,et al.  The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins. , 1992, The Journal of biological chemistry.

[16]  E. Fisher,et al.  Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. , 1992, The Journal of clinical investigation.

[17]  B. Mccarthy,et al.  Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs. , 1992, The Journal of biological chemistry.

[18]  V. Lingappa,et al.  Pause transfer: A topogenic sequence in apolipoprotein B mediates stopping and restarting of translocation , 1992, Cell.

[19]  H. Ginsberg,et al.  Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. , 1991, The Journal of biological chemistry.

[20]  S. Young,et al.  Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells. Evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins. , 1991, The Journal of biological chemistry.

[21]  J. Borén,et al.  The molecular mechanism for the assembly and secretion of ApoB-100-containing lipoproteins. , 1991, Progress in lipid research.

[22]  N. Davidson,et al.  Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. , 1990, The Journal of biological chemistry.

[23]  S. Young Recent Progress in Understanding Apolipoprotein B , 1990, Circulation.

[24]  R. Davis,et al.  Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. , 1990, Journal of lipid research.

[25]  V. Lingappa,et al.  New variation on the translocation of proteins during early biogenesis of apolipoprotein B , 1990, Nature.

[26]  B. Mccarthy,et al.  An expression system for human apolipoprotein B100 in a rat hepatoma cell line. , 1990, The Journal of biological chemistry.

[27]  J. Sparks,et al.  Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. , 1990, The Journal of biological chemistry.

[28]  G. Gibbons Assembly and secretion of hepatic very-low-density lipoprotein. , 1990, The Biochemical journal.

[29]  E. Rassart,et al.  The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. , 1989, The Journal of biological chemistry.

[30]  J. Boyles,et al.  A rapid method for staining large chylomicrons. , 1989, Journal of lipid research.

[31]  M. Wilson,et al.  Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol. , 1989, The Journal of biological chemistry.

[32]  M. Hussain,et al.  Synthesis, modification, and flotation properties of rat hepatocyte apolipoproteins. , 1989, Biochimica et biophysica acta.

[33]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[34]  K. Svenson,et al.  Biosynthetic relationships between three rat apolipoprotein B peptides. , 1988, Journal of lipid research.

[35]  J. Scott,et al.  Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. , 1988, The Journal of biological chemistry.

[36]  D. Vance,et al.  The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. , 1988, The Journal of biological chemistry.

[37]  R. Mahley,et al.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100. , 1987, The Journal of clinical investigation.

[38]  Z W Gu,et al.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.

[39]  H. Brewer,et al.  Identification of a novel in-frame translational stop codon in human intestine apoB mRNA. , 1987, Biochemical and biophysical research communications.

[40]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.

[41]  H. G. Windmueller,et al.  Regulated biosynthesis and divergent metabolism of three forms of hepatic apolipoprotein B in the rat. , 1985, Journal of lipid research.

[42]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[43]  C. Sparks,et al.  The Effect of Fasting on the Secretion of Lipoproteins and Two Forms of Apo B by Perfused Rat Liver , 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  D. Steinberg,et al.  Very low density lipoprotein synthesis and secretion by cultured rat hepatocytes. , 1979, The Journal of biological chemistry.

[45]  R. Havel,et al.  Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liver. , 1977, Metabolism: clinical and experimental.